The state of South Dakota currently has 1 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including Sioux Falls, Rapid City, Aberdeen and Watertown.
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.
Recruiting
Study to investigate the efficacy and safety of two doses of K-808 (pemafribate) in subjects with PBC.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/03/2024
Locations: Rapid City Medical Center, Rapid City, South Dakota
Conditions: Primary Biliary Cholangitis